Gliosarcoma is a rare variant of glioblastoma multiforme characterized by a biphasic pattern of glial and mesenchymal differentiation. Fine-needle aspiration (FNA) is routinely employed to diagnose a number of primary and secondary malignancies in a variety of clinical settings. Herein, we describe the cytomorphologic features of a gliosarcoma metastatic to an extracranial location accompanied by corresponding clinico-radiologic and histopathologic findings in a 51-year-old man with a posterior mediastinal mass. The cytologic smears displayed a pleomorphic tumor comprised of spindled and epithelioid malignant cells. This case illustrates the ability of FNA to adequately diagnose a rare malignancy in the appropriate clinico-radiologic setting.

1.
Ostrom QT, et al: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 2014;16(suppl 4):iv1-iv63.
2.
Cachia D, et al: Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol 2015;125:401-410.
3.
Louis D, et al: WHO Classification of Tumours of the Central Nervous System. Lyon, IARC Press, 2016.
4.
Karsy M, et al: Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features. Folia Neuropathol 2012;50:301-321.
5.
Schrantz JL, Araoz CA: Radiation induced meningeal fibrosarcoma. Arch Pathol 1972;93:26-31.
6.
Kondziolka D, et al: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997;41:776-783, discussion 783-785.
7.
Beaumont TL, et al: Gliosarcoma with multiple extracranial metastases: case report and review of the literature. J Neurooncol 2007;83:39-46.
8.
Moon KS, et al: Metastatic glioblastoma in cervical lymph node after repeated craniotomies: report of a case with diagnosis by fine needle aspiration. J Korean Med Sci 2004;19:911-914.
9.
Chivukula M, et al: FNAB cytology of extra-cranial metastasis of glioblastoma multiforme may resemble a lung primary: a diagnostic pitfall. Cytojournal 2005;2:9.
10.
Romero-Rojas AE, et al: Glioblastoma metastasis to parotid gland and neck lymph nodes: fine-needle aspiration cytology with histopathologic correlation. Head Neck Pathol 2013;7:409-415.
11.
Nauen DW, Li QK: Cytological diagnosis of metastatic glioblastoma in the pleural effusion of a lung transplant patient. Diagn Cytopathol 2014;42:619-623.
12.
Galanis E, et al: Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg 1998;89:425-430.
13.
Han SJ, et al: Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 2010;116:1358-1366.
14.
Han SJ, et al: Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol 2010;96:313-320.
15.
Ozolek JA, Finkelstein SD, Couce ME: Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization - a case report and review of the literature. Mod Pathol 2004;17:739-745.
16.
Huo Z, et al: Primary gliosarcoma with long-survival: report of two cases and review of literature. Int J Clin Exp Pathol 2014;7:6323-6332.
17.
Smith DR, Hardman JM, Earle KM: Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis. Cancer 1969;24:270-276.
18.
Gjerdrum LM, Bojsen-Moller M: October 1998 - 61 year old male with brain tumor and oral, lung, and palpebral masses. Brain Pathol 1999;9:421-422.
19.
Ojeda VJ, Sterrett GF: Cerebral gliosarcoma, pulmonary adenoid-cystic carcinoma, and pulmonary metastatic gliosarcoma: report of an untreated case. Pathology 1984;16:217-221.
20.
Weaver D, et al: Selective peripancreatic sarcoma metastases from primary gliosarcoma: case report. J Neurosurg 1984;61:599-601.
21.
Marchevsky AM: Mediastinal tumors of peripheral nervous system origin. Semin Diagn Pathol 1999;16:65-78.
22.
Parwani AV, et al: Gliosarcoma: cytopathologic characteristics on fine-needle aspiration (FNA) and intraoperative touch imprint. Diagn Cytopathol 2004;30:77-81.
23.
Wharton SB, et al: Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis. Clin Neuropathol 2001;20:212-218.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.